
Comparison of everolimus- and paclitaxel-eluting stents in dialysis patients
Keywords: بیماری کلیوی در مرحله پایانی; ESRD; end-stage renal disease; MACE; major adverse cardiac event; SES; sirolimus-eluting stent; TLR; target lesion revascularization; PES; paclitaxel-eluting stent; PCI; percutaneous coronary intervention; EES; everolimus-eluting stent; CKD; chronic kidne